Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Decibel Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −1 vs. Q4 2021
- Shares held
- 17.7M
- +131.9K (+0.8%) vs. Q4 2021
- Total value
- $53.8M
- −$27.9M (−34.1%) vs. Q4 2021
- New holders
- 4
- 9 more added
- Sold out
- 5
- 9 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $36.4K |
| Q3 2023 | 1 | $36.4K |
| Q2 2023 | 37 | $59.2M |
| Q1 2023 | 38 | $46.7M |
| Q4 2022 | 39 | $35.8M |
| Q3 2022 | 40 | $62.1M |
| Q2 2022 | 42 | $75.2M |
| Q1 2022 | 39 | $53.8M |
| Q4 2021 | 40 | $81.7M |
| Q3 2021 | 36 | $145.9M |
| Q2 2021 | 46 | $168.1M |
| Q1 2021 | 54 | $226.3M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Decibel Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 4,945,192 | $15.0M | 0.24% | 00.0% | Unchanged |
| TRV GP III, LLC | 3,139,685 | $9.54M | 2.59% | 00.0% | Unchanged |
| BlackRock Inc. | 1,897,223 | $5.77M | 0.00% | +801,010+73.1% | Added |
| Citadel Advisors LLC | 1,773,691 | $5.39M | 0.01% | +1300.0% | Added |
| Alphabet Inc. | 1,636,258 | $4.97M | 0.16% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 826,422 | $2.51M | 0.64% | 00.0% | Unchanged |
| Vanguard Group Inc | 622,937 | $1.89M | 0.00% | −1,860−0.3% | Reduced |
| Bessemer Group Inc | 494,071 | $1.50M | 0.00% | 00.0% | Unchanged |
| Casdin Capital, LLC | 330,000 | $1.00M | 0.04% | −840,048−71.8% | Reduced |
| Harvard Management Co Inc | 328,798 | $1.00M | 0.10% | 00.0% | Unchanged |
| Woodline Partners LP | 275,001 | $836.0K | 0.01% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 263,600 | $801.0K | 0.02% | 00.0% | Unchanged |
| Barclays PLC | 240,337 | $731.0K | 0.00% | +240,337 | New |
| Bronte Capital Management Pty Ltd. | 163,224 | $496.0K | 0.07% | +6,008+3.8% | Added |
| JPMorgan Chase & Co | 156,369 | $476.0K | 0.00% | −4,156−2.6% | Reduced |
| Bridgeway Capital Management, LLC | 114,928 | $349.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 69,283 | $210.0K | 0.00% | 00.0% | Unchanged |
| Neuberger Berman Group LLC | 62,825 | $191.0K | 0.00% | +3,255+5.5% | Added |
| Atlas Capital Advisors LLC | 41,025 | $124.7K | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 39,074 | $119.0K | 0.00% | +418+1.1% | Added |
| Bank of New York Mellon Corp | 27,310 | $83.0K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 25,704 | $78.0K | 0.02% | +7,232+39.2% | Added |
| Morgan Stanley | 22,841 | $69.0K | 0.00% | +9,579+72.2% | Added |
| Two Sigma Investments, LP | 22,308 | $68.0K | 0.00% | −25,060−52.9% | Reduced |
| Renaissance Technologies LLC | 20,915 | $64.0K | 0.00% | −29,985−58.9% | Reduced |
| MYDA Advisors LLC | 20,000 | $61.0K | 0.03% | +20,000 | New |
| Bailard, Inc. | 19,700 | $60.0K | 0.00% | +19,700 | New |
| Bank of America Corp | 18,689 | $56.0K | 0.00% | +4,966+36.2% | Added |
| Susquehanna International Group, LLP | 16,846 | $51.0K | 0.00% | −22,580−57.3% | Reduced |
| State Street Corp | 16,260 | $49.0K | 0.00% | +560+3.6% | Added |
| Federated Hermes, Inc. | 15,000 | $46.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 14,239 | $43.0K | 0.00% | 00.0% | Unchanged |
| Laurion Capital Management LP | 11,990 | $36.0K | 0.00% | −3,063−20.3% | Reduced |
| Flagship Harbor Advisors, LLC | 10,113 | $31.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 4,283 | $13.0K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 3,200 | $9.00K | 0.01% | +3,200 | New |
| Tower Research Capital LLC (TRC) | 694 | $2.00K | 0.00% | −715−50.7% | Reduced |
| Citigroup Inc | 531 | $2.00K | 0.00% | −220−29.3% | Reduced |
| Financial Connections Group, Inc. | 300 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 0 | $0 | 0.00% | −43,500−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −11,300−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −867−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,075−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −95−100.0% | Sold out |